RHYTHM PHARMACEUTICALS, INC.

By person

38 insiders · 351 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Foley Todd

Director

$1.70M (1)

$50.56M (47)

−$48.86M

909,258

1.32%

$95.64M

+122.9%

Smith Hunter C

Chief Financial Officer

—

$19.38M (51) scheduled

−$19.38M

114,024

0.1656%

$11.99M

—

Lee Jennifer Kayden

EVP, Head of North America

—

$16.91M (36) scheduled

−$16.91M

0.0000%

$0.00

−100.0%

Shulman Joseph

Chief Technical Officer

—

$15.73M (41) scheduled

−$15.73M

15,915

0.0231%

$1.67M

—

BAKER BROS. ADVISORS LP entity

Former 10% owner

$15.05M (2)

—

+$15.05M

1,878,242

2.73%

$197.57M

—

RA CAPITAL MANAGEMENT, L.P. entity

Former 10% Owner

—

$13.40M (12)

−$13.40M

4,360,860

6.33%

$458.72M

−10.7%

Mazabraud Yann

EVP, Head of International

—

$12.84M (17) scheduled

−$12.84M

55,655

0.0808%

$5.85M

+168.4%

Cramer Pamela J.

Chief Human Resources Officer

—

$10.96M (32) scheduled

−$10.96M

29,376

0.0427%

$3.09M

+1,080%

Meeker David P

President and CEO

$626.71K (2)

$10.77M (11) scheduled

−$10.15M

239,258

0.3475%

$25.17M

+752.3%

BARRETT M JAMES

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

BARRIS PETER J

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

BASKETT FOREST

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

KERINS PATRICK J

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

MOTT DAVID M

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

NEW ENTERPRISE ASSOCIATES 13 LP entity

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

SANDELL SCOTT D

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Viswanathan Ravi

10% owner

$9.35M (1)

—

+$9.35M

4,909,956

7.13%

$516.48M

+16,613%

Flynn James E

10% owner

$6.04M (2)

—

+$6.04M

468,505

0.6805%

$49.28M

—

TETRAULT LYNN A.

Director

—

$5.40M (8) scheduled

−$5.40M

11,712

0.0170%

$1.23M

—

GOOD JENNIFER L

Director

—

$4.27M (3) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

MCGIRR DAVID W J

Director

—

$4.27M (2) scheduled

−$4.27M

11,712

0.0170%

$1.23M

—

Van der Ploeg Leonardus H.T.

Chief Scientific Officer

—

$2.73M (11) scheduled

−$2.73M

42,339

0.0615%

$4.45M

−34.2%

Gottesdiener Keith Michael

CEO & President

—

$2.48M (15)

−$2.48M

558,250

0.8108%

$58.72M

−0.3%

MPM BIOVENTURES V, L.P.

10% owner

$1.70M (1)

—

+$1.70M

2,696,392

3.92%

$283.63M

+9,078%

German Christopher Paul

Corporate Controller & CAO

—

$1.59M (9) scheduled

−$1.59M

0.0000%

$0.00

−100.0%

Desikan Nithya

Chief Commercial Officer

—

$1.55M (2) scheduled

−$1.55M

43,602

0.0633%

$4.59M

—

ORBIMED ADVISORS LLC entity

10% owner

$6.04M (1)

$4.66M (4)

+$1.37M

2,750,079

3.99%

$289.28M

—

Garfield Alastair

Chief Scientific Officer

—

$998.19K (6) scheduled

−$998.19K

2,295

0.0033%

$241.41K

—

PFIZER INC entity

10% owner

$680.00K (1)

—

+$680.00K

1,427,639

2.07%

$150.17M

—

Ipsen, S.A.

10% owner

$340.00K (1)

—

+$340.00K

833,099

1.21%

$87.63M

+39.0%

Roberts William T.

Chief Accounting Officer

—

$53.87K (3) scheduled

−$53.87K

7,872

0.0114%

$828.06K

+128.0%

THIRD ROCK VENTURES LP entity

10% owner

—

2,981,437

4.33%

$313.62M

+16,814%

Hadley Harbor Master Investors (Cayman) L.P.

10% owner

—

545,256

0.7919%

$57.36M

—

Mathers Edward T

Director

—

21,168

0.0307%

$2.23M

—

Arbuckle Stuart A

Director

—

11,712

0.0170%

$1.23M

—

JEAN CHRISTOPHE

Director

—

11,712

0.0170%

$1.23M

—

Bedrosian Camille L

Director

—

7,000

0.0102%

$736.33K

—

Exter Neil

Director

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

800

$119.17

$95.34K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

3,400

$118.28

$402.17K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

1,556

$117.08

$182.17K

Garfield Alastair

13 Aug 2026

Chief Scientific Officer

Sold on a plan

2,007

$116.11

$233.03K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

585

$103.28

$60.42K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

800

$102.10

$81.68K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

1,692

$100.92

$170.75K

Smith Hunter C

19 Feb 2026

Chief Financial Officer

Sold on a plan

1,308

$100.27

$131.15K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

200

$103.84

$20.77K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

1,069

$103.00

$110.11K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

900

$101.70

$91.53K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

200

$100.52

$20.10K

Smith Hunter C

17 Feb 2026

Chief Financial Officer

Sold on a plan

1,200

$99.42

$119.30K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

100

$100.10

$10.01K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

800

$98.99

$79.19K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

400

$97.67

$39.07K

Smith Hunter C

12 Feb 2026

Chief Financial Officer

Sold on a plan

292

$96.26

$28.11K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

100

$100.85

$10.09K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

400

$99.44

$39.77K

Smith Hunter C

11 Feb 2026

Chief Financial Officer

Sold on a plan

2,266

$98.37

$222.91K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

100

$104.76

$10.48K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

700

$103.68

$72.57K

Smith Hunter C

10 Feb 2026

Chief Financial Officer

Sold on a plan

1,913

$102.66

$196.38K

Smith Hunter C

5 Feb 2026

Chief Financial Officer

Sold on a plan

3,381

$106.06

$358.60K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

747

$107.67

$80.43K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

1,000

$106.60

$106.60K

Smith Hunter C

4 Feb 2026

Chief Financial Officer

Sold on a plan

1,500

$104.74

$157.12K

Cramer Pamela J.

29 Jul 2025

Chief Human Resources Officer

Sold on a plan

1,520

$85.93

$130.61K

Garfield Alastair

2 Jul 2025

Chief Scientific Officer

Sold on a plan

$64.60

$387.60

Garfield Alastair

2 Jul 2025

Chief Scientific Officer

Sold on a plan

1,313

$64.81

$85.10K

Mazabraud Yann

29 Apr 2025

EVP, Head of International

Sold on a plan

6,745

$65.08

$438.95K

Mazabraud Yann

8 Apr 2025

EVP, Head of International

Sold on a plan

9,312

$61.54

$573.06K

Mazabraud Yann

8 Apr 2025

EVP, Head of International

Sold on a plan

8,438

$60.37

$509.43K

Cramer Pamela J.

19 Feb 2025

Chief Human Resources Officer

Sold on a plan

982

$57.22

$56.19K

Lee Jennifer Kayden

19 Feb 2025

EVP, Head of North America

Sold on a plan

2,035

$57.22

$116.44K

Meeker David P

19 Feb 2025

President and CEO

Sold on a plan

9,896

$57.22

$566.25K

Shulman Joseph

19 Feb 2025

Chief Technical Officer

Sold on a plan

1,228

$57.22

$70.27K

Smith Hunter C

19 Feb 2025

Chief Financial Officer

Sold on a plan

2,215

$57.22

$126.74K

Lee Jennifer Kayden

13 Feb 2025

EVP, Head of North America

Sold on a plan

1,205

$58.00

$69.89K

Lee Jennifer Kayden

12 Feb 2025

EVP, Head of North America

Sold on a plan

1,205

$56.39

$67.95K

Lee Jennifer Kayden

12 Feb 2025

EVP, Head of North America

Sold on a plan

$56.41

$564.10

Lee Jennifer Kayden

12 Feb 2025

EVP, Head of North America

Sold on a plan

600

$56.39

$33.83K

Shulman Joseph

12 Feb 2025

Chief Technical Officer

Sold on a plan

$57.09

$399.63

Shulman Joseph

12 Feb 2025

Chief Technical Officer

Sold on a plan

462

$56.39

$26.05K

Smith Hunter C

12 Feb 2025

Chief Financial Officer

Sold on a plan

$56.22

$674.64

Smith Hunter C

12 Feb 2025

Chief Financial Officer

Sold on a plan

739

$56.39

$41.67K

Cramer Pamela J.

11 Feb 2025

Chief Human Resources Officer

Sold on a plan

$57.54

$172.62

Cramer Pamela J.

11 Feb 2025

Chief Human Resources Officer

Sold on a plan

698

$57.51

$40.14K

Lee Jennifer Kayden

10 Feb 2025

EVP, Head of North America

Sold on a plan

2,295

$59.34

$136.19K

Lee Jennifer Kayden

10 Feb 2025

EVP, Head of North America

Sold on a plan

1,894

$58.39

$110.60K

Lee Jennifer Kayden

5 Feb 2025

EVP, Head of North America

Sold on a plan

200

$61.95

$12.39K

Lee Jennifer Kayden

5 Feb 2025

EVP, Head of North America

Sold on a plan

1,133

$61.01

$69.13K

Lee Jennifer Kayden

5 Feb 2025

EVP, Head of North America

Sold on a plan

1,733

$60.08

$104.12K

Cramer Pamela J.

29 Jul 2024

Chief Human Resources Officer

Sold on a plan

1,395

$49.06

$68.44K

Shulman Joseph

14 Feb 2024

Chief Technical Officer

Sold on a plan

1,089

$50.01

$54.46K

Shulman Joseph

13 Feb 2024

Chief Technical Officer

Sold on a plan

473

$49.84

$23.57K

Shulman Joseph

13 Feb 2024

Chief Technical Officer

Sold on a plan

1,865

$50.00

$93.25K

Shulman Joseph

12 Feb 2024

Chief Technical Officer

Sold on a plan

791

$51.38

$40.64K

Showing 250 of 351 transactions. The figures above use every one of them.

RHYTHM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out